future of glp 1 drugs Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Why GLP-1 drugs are changing

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (T2D)

The fermentation of fiber in the gut leads to the production of short-chain fatty acids, which can stimulate GLP-1 secretion

A new study provides the first clinical evidence that popular semaglutide drugs, like Ozempic or Wegovy, could slow down processes associated with biological aging.

Explore the best GLP-1 for weight loss, comparing oral vs injectable semaglutide, side effects, and long-term tolerance to find the optimal treatment for your needs.

Aligning with the US FDAs draft guidance, Noom offers tailored tools and content to support improved patient outcomes as a companion app for weight loss medications.The label on GLP-1 medications says they are to be used in combination with a reduced-calorie diet and increased physical activity, says Noom CEO Geoff Cook.